Surveillance For New Lung Primaries
The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.
Checked against the public recordLast updated Nov 15, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Wisconsin, Madison
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * History squamous cell NSCLC who have undergone complete resection or definitive chemotherapy Exclusion Criteria: * History of an aerodigestive tract carcinoma of non-squamous histology * Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have undergone resection or chemotherapy within three years * Patients who have Stage I or II squamous cell lung cancer that have undergone resection or chemotherapy within one year * Patients who have received external beam radiation therapy for treatment of a squamous cell cancer of the lung
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Wisconsin Hospital and ClinicsMadison, Wisconsin
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 15, 2019. Always confirm current availability with the study team.